98 related articles for article (PubMed ID: 9389362)
1. Expression of p56lck in B-cell neoplasias.
Von Knethen A; Abts H; Kube D; Diehl V; Tesch H
Leuk Lymphoma; 1997 Aug; 26(5-6):551-62. PubMed ID: 9389362
[TBL] [Abstract][Full Text] [Related]
2. Activators of protein kinase C induce dissociation of CD4, but not CD8, from p56lck.
Hurley TR; Luo K; Sefton BM
Science; 1989 Jul; 245(4916):407-9. PubMed ID: 2787934
[TBL] [Abstract][Full Text] [Related]
3. Protein tyrosine phosphorylation and p56lck modification in IL-2 or phorbol ester-activated human natural killer cells.
Einspahr KJ; Abraham RT; Dick CJ; Leibson PJ
J Immunol; 1990 Sep; 145(5):1490-7. PubMed ID: 1696599
[TBL] [Abstract][Full Text] [Related]
4. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
[TBL] [Abstract][Full Text] [Related]
5. Cross-linking of CD4 induces cytoskeletal association of CD4 and p56lck.
Ha-Lee YM; Lee Y; Kim YK; Sohn J
Exp Mol Med; 2000 Mar; 32(1):18-22. PubMed ID: 10762057
[TBL] [Abstract][Full Text] [Related]
6. A lymphocyte-specific protein tyrosine kinase, p56lck, regulates the PMA-induced internalization of CD4.
Yoshida H; Koga Y; Nakamura K; Kimura G; Nomoto K
Biochim Biophys Acta; 1992 Nov; 1137(3):321-30. PubMed ID: 1280163
[TBL] [Abstract][Full Text] [Related]
7. Alterations in expression of p56lck during myeloid differentiation of LSTRA cells.
Garcia-Welsh A; Laskin DL; Molloy CJ; Laskin JD
Cell Growth Differ; 1994 Nov; 5(11):1215-23. PubMed ID: 7531490
[TBL] [Abstract][Full Text] [Related]
8. The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway.
Vockerodt M; Haier B; Buttgereit P; Tesch H; Kube D
Virology; 2001 Feb; 280(2):183-98. PubMed ID: 11162833
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes.
Hivroz C; Mazerolles F; Soula M; Fagard R; Graton S; Meloche S; Sekaly RP; Fischer A
Eur J Immunol; 1993 Mar; 23(3):600-7. PubMed ID: 7680610
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the sites in p56lck whose phosphorylation is induced by tetradecanoyl phorbol acetate.
Luo KX; Sefton BM
Oncogene; 1990 Jun; 5(6):803-8. PubMed ID: 2359619
[TBL] [Abstract][Full Text] [Related]
11. In vivo association between p56lck and MAP kinase during IL-2-mediated lymphocyte proliferation.
Taieb J; Blanchard DA; Auffredou MT; Chaouchi N; Vazquez A
J Immunol; 1995 Dec; 155(12):5623-30. PubMed ID: 7499846
[TBL] [Abstract][Full Text] [Related]
12. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.
Wang Q; Stanley J; Kudoh S; Myles J; Kolenko V; Yi T; Tubbs R; Bukowski R; Finke J
J Immunol; 1995 Aug; 155(3):1382-92. PubMed ID: 7636203
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 infection is facilitated in T cells by decreasing p56lck protein tyrosine kinase activity.
Yousefi S; Ma XZ; Singla R; Zhou YC; Sakac D; Bali M; Liu Y; Sahai BM; Branch DR
Clin Exp Immunol; 2003 Jul; 133(1):78-90. PubMed ID: 12823281
[TBL] [Abstract][Full Text] [Related]
14. Both T cell receptor (TcR)-CD3 complex and CD2 increase the tyrosine kinase activity of p56lck. CD2 can mediate TcR-CD3-independent and CD45-dependent activation of p56lck.
Danielian S; Alcover A; Polissard L; Stefanescu M; Acuto O; Fischer S; Fagard R
Eur J Immunol; 1992 Nov; 22(11):2915-21. PubMed ID: 1358625
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C plays a role in the induction of tyrosine phosphorylation of lymphoid microtubule-associated protein-2 kinase. Evidence for a CD3-associated cascade that includes pp56lck and that is defective in HPB-ALL.
Nel AE; Hanekom C; Hultin L
J Immunol; 1991 Sep; 147(6):1933-9. PubMed ID: 1716287
[TBL] [Abstract][Full Text] [Related]
16. The tyrosine kinase p56lck mediates activation of swelling-induced chloride channels in lymphocytes.
Lepple-Wienhues A; Szabò I; Laun T; Kaba NK; Gulbins E; Lang F
J Cell Biol; 1998 Apr; 141(1):281-6. PubMed ID: 9531565
[TBL] [Abstract][Full Text] [Related]
17. An alternative pathway for expression of p56lck from type I promoter transcripts in colon carcinoma.
McCracken S; Kim CS; Xu Y; Minden M; Miyamoto NG
Oncogene; 1997 Dec; 15(24):2929-37. PubMed ID: 9416836
[TBL] [Abstract][Full Text] [Related]
18. Immobilized antibodies to CD45 induce rapid morphologic changes and increased tyrosine phosphorylation of p56lck-associated proteins in T cells.
Arendt CW; Hsi G; Ostergaard HL
J Immunol; 1995 Dec; 155(11):5095-103. PubMed ID: 7594518
[TBL] [Abstract][Full Text] [Related]
19. The tyrosine kinase lck is critically involved in the growth transformation of human B lymphocytes.
Cheung RK; Dosch HM
J Biol Chem; 1991 May; 266(14):8667-70. PubMed ID: 1709155
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD3 and phorbol ester induce distinct phosphorylated sites in the SH2 domain of p56lck.
Soula M; Rothhut B; Camoin L; Guillaume JL; Strosberg D; Vorherr T; Burn P; Meggio F; Fischer S; Fagard R
J Biol Chem; 1993 Dec; 268(36):27420-7. PubMed ID: 8262984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
